Chan R K, Raman J, Lee K J, Rosalion A, Hicks R J, Pornvilawan S, Sia B S, Horowitz J D, Tonkin A M, Buxton B F
Department of Cardiac Surgery, Austin and Repatriation Medical Center, Melbourne, Australia.
Ann Thorac Surg. 1996 May;61(5):1428-34. doi: 10.1016/0003-4975(96)00089-6.
In patients with poor left ventricular function, the determinants of outcome after revascularization are unknown.
We studied prospectively 57 patients with stable coronary artery disease and poor left ventricular function (left ventricular ejection fraction, 0.28 +/- 0.04) who underwent coronary artery bypass grafting. Clinical variables were assessed as predictors of outcome in all patients, and preoperative stress thallium-201 scintigraphic data were analysed in 37 patients.
The operative mortality was 1.7%. At 12 months after operation, 46 of the 49 survivors were angina-free and 35 had fewer heart failure symptoms, but postoperative left ventricular ejection fraction (0.30 +/- 0.09) did not change significantly. Eighteen survivors had left ventricular ejection fraction improved by 0.05 or more (0.30 +/- 0.03 preoperatively, 0.40 +/- 0.05 postoperatively; p = 0.0001). The adjusted odds ratio of large reversible thallium-201 defects in predicting such outcome was 15 (95% confidence interval, 1.6 to 140), whereas other clinical variables had no predictive value. The transplantation-free 5-year survival was 73%.
In patients with poor left ventricular function, surgical revascularization can be performed safely, with good symptomatic relief and long-term survival. One-year survival and improvement in left ventricular function is better in patients with large reversible defects on preoperative stress thallium-201 scintigraphy.
在左心室功能较差的患者中,血运重建术后的预后决定因素尚不清楚。
我们前瞻性地研究了57例稳定型冠状动脉疾病且左心室功能较差(左心室射血分数为0.28±0.04)并接受冠状动脉旁路移植术的患者。评估所有患者的临床变量作为预后预测指标,并对37例患者的术前应激铊-201闪烁扫描数据进行分析。
手术死亡率为1.7%。术后12个月时,49例幸存者中有46例无心绞痛,35例心力衰竭症状减轻,但术后左心室射血分数(0.30±0.09)无显著变化。18例幸存者的左心室射血分数提高了0.05或更多(术前为0.30±0.03,术后为0.40±0.05;p = 0.0001)。预测此类预后的大的可逆性铊-201缺损的校正比值比为15(95%置信区间,1.6至140),而其他临床变量无预测价值。无移植的5年生存率为73%。
在左心室功能较差的患者中,手术血运重建可以安全地进行,症状缓解良好且长期生存。术前应激铊-201闪烁扫描显示有大的可逆性缺损的患者1年生存率和左心室功能改善情况更好。